118 related articles for article (PubMed ID: 23414836)
41. Clinical use of liver biopsy for the diagnosis and management of inactive and asymptomatic hepatitis B virus carriers in Bangladesh.
Al-Mahtab M; Rahman S; Akbar SM; Kamal M; Khan MS
J Med Virol; 2010 Aug; 82(8):1350-4. PubMed ID: 20572087
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of liver biopsy in Egyptian HBeAg-negative chronic hepatitis B patients at initial presentation: implications for therapy.
El-Zayadi AR; Badran HM; Saied A; Shawky S; Attia Mel-D; Zalata K
Am J Gastroenterol; 2009 Apr; 104(4):906-11. PubMed ID: 19293791
[TBL] [Abstract][Full Text] [Related]
43. Isolated core antibody hepatitis B in sub-Saharan African immigrants.
Gibney KB; Torresi J; Lemoh C; Biggs BA
J Med Virol; 2008 Sep; 80(9):1565-9. PubMed ID: 18649341
[TBL] [Abstract][Full Text] [Related]
44. Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.
Fung J; Lai CL; Young J; Wong DK; Yuen J; Seto WK; Yuen MF
Am J Gastroenterol; 2011 Oct; 106(10):1766-73. PubMed ID: 21826112
[TBL] [Abstract][Full Text] [Related]
45. Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.
Pellicelli AM; Barbaro G; Francavilla R; Romano M; Barbarini G; Mazzoni E; Mecenate F; Paffetti A; Barlattani A; Struglia C; Villani R; Nauri L; Nosotti L; Armignacco O; Ferri F; Camporiondo MP; Soccorsi F;
Clin Ther; 2008 Feb; 30(2):317-23. PubMed ID: 18343270
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider.
Bahcecioglu IH; Aygun C; Gozel N; Poyrazoglu OK; Bulut Y; Yalniz M
J Viral Hepat; 2011 Jul; 18(7):518-24. PubMed ID: 20546500
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels.
Lin CL; Liao LY; Liu CJ; Yu MW; Chen PJ; Lai MY; Chen DS; Kao JH
Hepatology; 2007 May; 45(5):1193-8. PubMed ID: 17464993
[TBL] [Abstract][Full Text] [Related]
48. Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels.
Nakazawa T; Shibuya A; Takeuchi A; Shibata Y; Hidaka H; Okuwaki Y; Takada J; Tanaka Y; Watanabe M; Minamino T; Sakurai K; Koizumi W
J Viral Hepat; 2011 Jul; 18(7):e191-9. PubMed ID: 21692932
[TBL] [Abstract][Full Text] [Related]
49. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.
Liu J; Yang HI; Lee MH; Lu SN; Jen CL; Wang LY; You SL; Iloeje UH; Chen CJ;
Gastroenterology; 2010 Aug; 139(2):474-82. PubMed ID: 20434450
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
[TBL] [Abstract][Full Text] [Related]
51. Epidemiology, course and disease burden of chronic hepatitis B virus infection. HEPNET study for chronic hepatitis B: a multicentre Greek study.
Raptopoulou M; Papatheodoridis G; Antoniou A; Ketikoglou J; Tzourmakliotis D; Vasiliadis T; Manolaki N; Nikolopoulou G; Manesis E; Pierroutsakos I
J Viral Hepat; 2009 Mar; 16(3):195-202. PubMed ID: 19175881
[TBL] [Abstract][Full Text] [Related]
52. Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients.
Jeng WJ; Sheen IS; Chen YC; Hsu CW; Chien RN; Chu CM; Liaw YF
Hepatology; 2013 Dec; 58(6):1888-96. PubMed ID: 23744454
[TBL] [Abstract][Full Text] [Related]
53. Evidence for the insufficient evaluation and undertreatment of chronic hepatitis B infection in a predominantly low-income and immigrant population.
Jung CW; Tan J; Tan N; Kuo MN; Ashok A; Eells SJ; Miller LG
J Gastroenterol Hepatol; 2010 Feb; 25(2):369-75. PubMed ID: 19929923
[TBL] [Abstract][Full Text] [Related]
54. Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.
Yalçin K; Değertekin H; Alp MN; Tekeş S; Satici O; Budak T
Turk J Gastroenterol; 2003 Sep; 14(3):157-63. PubMed ID: 14655057
[TBL] [Abstract][Full Text] [Related]
55. Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China.
Zeng G; Wang Z; Wen S; Jiang J; Wang L; Cheng J; Tan D; Xiao F; Ma S; Li W; Luo K; Naoumov NV; Hou J
J Viral Hepat; 2005 Nov; 12(6):609-17. PubMed ID: 16255762
[TBL] [Abstract][Full Text] [Related]
56. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong.
Chan HL; Leung NW; Hussain M; Wong ML; Lok AS
Hepatology; 2000 Mar; 31(3):763-8. PubMed ID: 10706570
[TBL] [Abstract][Full Text] [Related]
57. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
[TBL] [Abstract][Full Text] [Related]
58. Comparative analysis of disease activity in patients of chronic hepatitis B virus, with and without superinfection with hepatitis D virus; an experience at tertiary care centre.
Das K; Ali H; Mahmood T; Munir SM; Ahmed T; Farooq MU
J Ayub Med Coll Abbottabad; 2008; 20(2):39-42. PubMed ID: 19385455
[TBL] [Abstract][Full Text] [Related]
59. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.
Brunetto MR; Oliveri F; Colombatto P; Moriconi F; Ciccorossi P; Coco B; Romagnoli V; Cherubini B; Moscato G; Maina AM; Cavallone D; Bonino F
Gastroenterology; 2010 Aug; 139(2):483-90. PubMed ID: 20451520
[TBL] [Abstract][Full Text] [Related]
60. HBV DNA level and antigen concentration in evaluating liver damage of patients with chronic hepatitis B.
Xie Y; Zhao H; Dai WS; Xu DZ
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):418-22. PubMed ID: 14599951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]